483 Cangene BioPharma Dec 2016

483 Cangene BioPharma Dec 2016

Steven Donald FDA$595.00 - Available Now

FDA investigators audited the Cangene BioPharma - Baltimore, MD, United States facility and issued inspectional observations (via FDA 483) on 20 Dec 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 20 Dec 2016
  • Location: Baltimore, United States
  • FEI: 1000512361
Add To Cart